Publications
Specialty
Search
Psych Congress Network
07/24/2024
Ketamine was associated with greater treatment response than electroconvulsive therapy in patients with nonpsychotic treatment-resistant depression who had moderately severe or severe pretreatment symptoms and who initiated treatment as outpatients.
Vascular Disease Management, CardioVascular
07/24/2024
Constantino S. Peña, MD, interventional radiologist at the Miami Cardiac and Vascular Institute, presented several sessions at SIR, including one on this topic. VDM spoke with Dr. Pena about his presentation.
Psych Congress Network
07/24/2024
The US Food and Drug Administration recently accepted a supplemental New Drug Application for brexpiprazole in combination with sertraline for the treatment of adults with PTSD, announced codevelopers Otsuka Pharmaceutical Co. Ltd. and H. Lundbeck A/S.
Journal of Invasive Cardiology
07/24/2024
Video Supplement to "Kissing-Catheter Technique in Percutaneous Transcatheter Closure of Patent Ductus Arteriosus: A Snare-Free Approach" (Original Contribution).
Journal of Invasive Cardiology, CardioVascular
07/24/2024
The authors propose a new snare-free method that can be used as an alternative approach for cases of patent ductus arteriosus percutaneous closure where the antegrade approach is difficult.
EMSWorld
07/24/2024
The National Weather Service predicted that it will be a "long-duration heat wave," which creates uniquely dangerous conditions — especially when temperatures barely drop at night.
EP Lab Digest
07/24/2024
Peerbridge Health Press Release
NEW YORK, July 24, 2024 -- Peerbridge Health today announced the beginning of enrollment for its Ejection Fraction AI-enabled Clinical Trial (EF-ACT) pivotal trial to determine Left Ventricular Ejection Fraction (LVEF) severity directly from its AI-enabled Peerbridge Cor™ remote wearable electrocardiogram (ECG) device. This will enable on-demand assessments of EF Severity on the American Society of Echocardiography scale and will be available anytime in all settings – in clinic and at home.
EP Lab Digest
07/24/2024
Collaboration aims to address challenges in capturing and analyzing cardiac signals to help physicians enhance patient outcomes for atrial fibrillation procedures
EP Lab Digest
07/24/2024
BioCardia Press Release
SUNNYVALE, Calif., July 17, 2024 -- BioCardia, Inc. [Nasdaq: BCDA], a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases today announces that the Unites States Patent Office has granted Patent No: 12,036,371 titled “Method of Accessing the Left Atrium with a Multi-Directional Steerable Catheter,” with a patent term that will expire in 2035.
EP Lab Digest
07/24/2024
AtriCure Press Release
First Report Managed Care, Population Health
07/24/2024
The M3P offers financial relief by spreading payment throughout the year, and CMS’ latest guidance clarifies key outreach parameters.
EMSWorld
07/24/2024
New York City EMS leaders to share lessons from Ground Zero and the lasting impact of September 11, 2001, on the EMS community.
Gastroenterology
07/24/2024
C olorectal cancer, colon cancer, and noncardia gastric cancer were found to be associated with high consumption of ultraprocessed foods, according to recent research.
Gastroenterology, Advances in Inflammatory Bowel Disease Network
07/24/2024
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Annals of Long-Term Care
07/23/2024
A study assessed the safety and effectiveness of staged bilateral MRI-guided focused ultrasound subthalamotomy (FUS-STN) to treat Parkinson Disease (PD).
Wound Care
07/23/2024
StimLabs announced enrollment of the first patient in the CAMPSTIM multi-center RCT that aims to demonstrate the clinical outcomes of at least four of StimLabs' placental-based tissue products with standard of care (SOC) vs SOC alone in patients with hard-to-heal DFUs.
Wound Care
07/23/2024
Kerecis announced it has received approval from Palmetto GBA for the Kerecis Shield used in private doctor clinics. The approval means that 4 of the 7 insurance companies administering Medicare plans across the US have set a fee schedule for the Shield product line.
Wound Care
07/23/2024
IR-MED received a $500,000 grant from the Israel Innovation Authority to develop its platform technology for early detection of DFUs. DiaSafe is being developed to provide safe, real-time optical readings of biomarkers to detect the early signs of DFUs with accuracy. Bus Insider
Wound Care
07/23/2024
MediWound announced it has entered into a $25.0MM definitive share purchase agreement with several new and existing investors, including $15.0MM from Mölnlycke Health Care. The proceeds will fund advancing EscharEx pre-commercial activities and increasing manufacturing capacity.
Wound Care
07/23/2024
CMS released the Q224 Drug and Biologicals Final Quarterly Coding Decisions and added 12 new Q codes, including multiple new codes for Tides Medical's Artacent products, another new code for Merakris Therapeutics' Dermacyte and some newer players to wound care.